The effect of adenosine triphosphate on bevacizumab-induced ovarian damage and reproductive dysfunction in rats

ArticleAçık Erişim

Özet

We investigated the effect of ATP’s protection against possible bevacizumab-induced ovarian damage and reproductive dysfunction in female albino Wistar rats. A total of 42 rats, 36 females, and 6 males were used in the experiment. Normal saline (0.9% NaCl) was injected as a solvent to the Bevacizumab (BVZ; n = 12) and Control (n = 6) groups. 25 mg/kg ATP was injected intraperitoneally (i.p.) to the ATP + bevacizumab (ABZ; n = 12) group. One hour after ATP and solvent administration, 10 mg/kg bevacizumab was i.p. injected to the ABZ and BVZ groups. Bevacizumab was administered once a day every two weeks; ATP was administered one a day for 30 days. At the end of this period, six rats from each group were sacrificed with high dose of anesthesia (thiopental sodium 50 mg/kg) and biochemical and histopathological examinations were performed in ovarian tissues. Mature male rats were kept in the laboratory for two months to breed the remaining female animals. The values showed that the oxidant parameters increased in the ovarian tissue of the BVZ group compared to the healthy controls and the ABZ group, while antioxidant parameters decreased. The number of breeding animals was significantly decreased in the BVZ group compared to the Control and the ABZ groups. This result suggests that ATP may be effective in preventing oxidative damage to the ovaries and infertility induced by bevacizumab. © 2021, Slovak Academy of Sciences. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13150Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.4149/gpb_2020039Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorInce, Sefa
dc.contributor.authorOzer, Mehmet
dc.contributor.authorKadioğlu, Berrin Goktug
dc.contributor.authorKuzucu, Mehmet
dc.contributor.authorYilmaz, Sevil Karahan
dc.contributor.authorÖzkaraca, Mustafa
dc.contributor.authorGezer, Arzu
dc.contributor.authorSuleyman, Halis
dc.date.accessioned2026-10-18T20:27:59.435487221Z
dc.date.available2026-10-18T20:27:59.435487221Z
dc.date.issued2021
dc.description.abstractWe investigated the effect of ATP’s protection against possible bevacizumab-induced ovarian damage and reproductive dysfunction in female albino Wistar rats. A total of 42 rats, 36 females, and 6 males were used in the experiment. Normal saline (0.9% NaCl) was injected as a solvent to the Bevacizumab (BVZ; n = 12) and Control (n = 6) groups. 25 mg/kg ATP was injected intraperitoneally (i.p.) to the ATP + bevacizumab (ABZ; n = 12) group. One hour after ATP and solvent administration, 10 mg/kg bevacizumab was i.p. injected to the ABZ and BVZ groups. Bevacizumab was administered once a day every two weeks; ATP was administered one a day for 30 days. At the end of this period, six rats from each group were sacrificed with high dose of anesthesia (thiopental sodium 50 mg/kg) and biochemical and histopathological examinations were performed in ovarian tissues. Mature male rats were kept in the laboratory for two months to breed the remaining female animals. The values showed that the oxidant parameters increased in the ovarian tissue of the BVZ group compared to the healthy controls and the ABZ group, while antioxidant parameters decreased. The number of breeding animals was significantly decreased in the BVZ group compared to the Control and the ABZ groups. This result suggests that ATP may be effective in preventing oxidative damage to the ovaries and infertility induced by bevacizumab. © 2021, Slovak Academy of Sciences. All rights reserved.
dc.identifier.doi10.4149/gpb_2020039
dc.identifier.eissn1338-4325
dc.identifier.endpage78
dc.identifier.issn0231-5882
dc.identifier.issue1
dc.identifier.pmid33655892
dc.identifier.scopus2-s2.0-85102325267
dc.identifier.startpage71
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13150
dc.identifier.volume40
dc.identifier.wosWOS:000626280700006
dc.language.isoen
dc.publisherSlovak Academy of Sciences
dc.relation.ispartofGeneral Physiology and Biophysics
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectATP
dc.subjectBevacizumab
dc.subjectOvarian damage
dc.subjectReproductive dysfunction
dc.subjectVEGF-A
dc.subjectAdenosine Triphosphate
dc.subjectAnimals
dc.subjectAntioxidants
dc.subjectFemale
dc.subjectMale
dc.subjectOvary
dc.subjectOxidative Stress
dc.subjectRats
dc.subjectglutathione
dc.subjectglutathione disulfide
dc.subjectmalonaldehyde
dc.subjectreduced nicotinamide adenine dinucleotide phosphate
dc.subjectsodium chloride
dc.subjectsolvent
dc.subjectthiopental
dc.subjectvasculotropin A
dc.subjectantioxidant
dc.subjectadult
dc.subjectanesthesia induction
dc.subjectanimal cell
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectantioxidant activity
dc.subjectArticle
dc.titleThe effect of adenosine triphosphate on bevacizumab-induced ovarian damage and reproductive dysfunction in rats
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus9
rdl.citation.wos8
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)